- Company News: Johnson & Johnson (JNJ) quarterly results beat analysts’ expectations
Market news
15 October 2019
Company News: Johnson & Johnson (JNJ) quarterly results beat analysts’ expectations
Johnson & Johnson (JNJ) reported Q3 FY 2019 earnings of $2.12 per share (versus $2.05 in Q3 FY 2018), beating analysts’ consensus estimate of $2.01.
The company’s quarterly revenues amounted to $20.729 bln (+1.9% y/y), beating analysts’ consensus estimate of $20.142 bln.
The company also raised guidance for FY 2019, projecting EPS of $8.62-8.67 (versus its prior guidance of $8.53-8.63 and analysts’ consensus estimate of $8.61) and revenues of $81.8-82.3 bln (versus its prior guidance of $80.8-81.6 bln and analysts’ consensus estimate of $81.59 bln).
JNJ rose to $133.28 (+1.96%) in pre-market trading.
Market Focus
Material posted here is solely for information purposes and reliance on this may lead to losses. Past performances are not a reliable indicator of future results. Please read our full disclaimerOpen Demo Account & Personal Page